RCMI Coordinating Center (RCMI CC) Header Logo

Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.

Obert CA, Miller ML, Montgomery J, Adamkiewicz T, Tuomanen EI. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients. Antimicrob Agents Chemother. 2007 Jan; 51(1):386-9.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support